Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis

被引:1
|
作者
Mialhe, A
Lafanechère, L
Treilleux, I
Peloux, N
Dumontet, C
Brémond, A
Panh, MH
Payan, R
Wehland, J
Margolis, RL
Job, D
机构
[1] CEA, CS, DBMS, Inserm U366,Lab Cytosquelette, F-38054 Grenoble 9, France
[2] Ctr Leon Berard, Dept Anat & Cytol Pathol, F-69373 Lyon, France
[3] Clin Belledonne, F-38400 St Martin Dheres, France
[4] Gesell Biotechnol Forsch mbH, D-38092 Braunschweig, Germany
[5] CEA, CNRS, Inst Biol Struct JP Ebel, F-38027 Grenoble 1, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tubulin, the dimeric subunit of microtubules, is a major cell protein that is: centrally involved in cell division, Tubulin is subject to specific enzymatic posttranslational modifications including cyclic tyrosine removal and addition at the COOK terminus of the cr-subunit. Tubulin is normally extensively tyrosinated in cycling cells. However, we have previously shown that detyrosinated tubulin accumulates in cancer cells during tumor progression in nude mice. Tubulin detyrosination, resulting from suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells. We have now analyzed the occurrence and significance of tubulin detyrosination in human breast tumors. We studied a total of 134 breast cancer tumors from patients with or without known complications over a follow-up period of 31 +/- 10 months. The mean age of the patients at the time of diagnosis was 57 years. For each patient, detailed data concerning the histology and extension of the tumor were available. Tumor cells containing detyrosinated tubulin were visualized by immunohistochemical staining of paraffin-embedded tissue sections. Cancer cells with detyrosinated tubulin were observed in 53% of the tumors and were predominant in 19.4% of the turners. Tubulin detyrosination correlated to a high degree of significance (P < 0.001) with a high Scarf;Bloom-Richardson (SBR) grade, a known marker of tumor aggressiveness. Among SBR grade 1 tumors, 3.8% were strongly positive for tubulin detyrosination compared with 65.4% of the SBR grade 3 tumors. The SBR component showing the strongest correlation with tubulin detyrosination was the mitotic score. In the entire patient population, neither the SBR grade nor the detyrosination index had significant prognostic value (P = 0.11, P = 0.27, respectively), whereas a combined index was significantly correlated with the clinical outcome (P = 0.02), A preliminary subgroup analysis indicated that tubulin detyrosination may define high- and low- risk groups in breast cancer tumors with an SBR grade of 2. Our study shows that tubulin detyrosination is a frequent occurrence in breast cancer, easy to detect, and linked to tumor aggressiveness.
引用
收藏
页码:5024 / 5027
页数:4
相关论文
共 50 条
  • [31] ALK alteration is a frequent event in aggressive breast cancers
    Abdul K. Siraj
    Shaham Beg
    Zeenath Jehan
    Sarita Prabhakaran
    Maqbool Ahmed
    Azhar R.Hussain
    Fouad Al-Dayel
    Asma Tulbah
    Dahish Ajarim
    Khawla S. Al-Kuraya
    Breast Cancer Research, 17
  • [32] OCCURRENCE AND PROGNOSIS OF CONTRALATERAL CARCINOMA OF THE BREAST
    SINGLETARY, SE
    TAYLOR, SH
    GUINEE, VF
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1994, 178 (04) : 390 - 396
  • [33] CA IX is an independent predictor of poor prognosis in breast carcinoma: Results from a population based study of 4150 breast cancers
    Clarke, BA
    Cheang, MC
    Rajput, A
    Chia, SK
    Gilks, CB
    Huntsman, DG
    LABORATORY INVESTIGATION, 2006, 86 : 24A - 24A
  • [34] CA IX is an independent predictor of poor prognosis in breast carcinoma: Results from a population based study of 4150 breast cancers
    Clarke, BA
    Cheang, MC
    Rajput, A
    Chia, SK
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2006, 19 : 24A - 24A
  • [35] ANALYSIS OF THE PROGNOSIS OF MINIMAL AND OCCULT BREAST CANCERS
    UNZEITIG, GW
    FRANKL, G
    ACKERMAN, M
    OCONNELL, TX
    ARCHIVES OF SURGERY, 1983, 118 (12) : 1403 - 1404
  • [36] Telomerase activity and prognosis in primary breast cancers
    Carey, LA
    Kim, NW
    Goodman, S
    Marks, J
    Henderson, G
    Umbricht, CB
    Dome, JS
    Dooley, W
    Amshey, SR
    Sukumar, S
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3075 - 3081
  • [37] Hematologic markers of distant metastases and poor prognosis in gynecological cancers
    O. Abu-Shawer
    M. Abu-Shawer
    N. Hirmas
    A. Alhouri
    A. Massad
    B. Alsibai
    H. Sultan
    H. Hammo
    M. Souleiman
    Y. Shebli
    M. Al-Hussaini
    BMC Cancer, 19
  • [38] Heparanase expression correlates with invasion and poor prognosis in gastric cancers
    Takaoka, M
    Naomoto, Y
    Ohkawa, T
    Uetsuka, H
    Shirakawa, Y
    Uno, F
    Fujiwara, T
    Gunduz, M
    Nagatsuka, H
    Nakajima, M
    Tanaka, N
    Haisa, M
    LABORATORY INVESTIGATION, 2003, 83 (05) : 613 - 622
  • [39] Strategies for improving the outcome of patients with poor prognosis prostate cancers
    Hanks, GE
    ACTA ONCOLOGICA, 1998, 37 (01) : 5 - 9
  • [40] Hematologic markers of distant metastases and poor prognosis in gynecological cancers
    Abu-Shawer, O.
    Abu-Shawer, M.
    Hirmas, N.
    Alhouri, A.
    Massad, A.
    Alsibai, B.
    Sultan, H.
    Hammo, H.
    Souleiman, M.
    Shebli, Y.
    Al-Hussaini, M.
    BMC CANCER, 2019, 19 (1)